Areas of business

The world is changing faster than ever before. And we are keeping up.

As an industrial group, Peppermint is involved in the business areas of sustainable and innovative textiles and the industrial Internet of Things. In addition, we invest in forward-looking companies and manage a venture capital fund. We have already successfully closed another fund.


We develop and produce innovative worsted yarns and jacquard fabrics for the corporate, protection, mobility, industry, interior and fashion sectors. We also create individual special solutions for very specific and complex requirements.


Zwickauer Kammgarn GmbH (ZKS) develops and produces high-quality and innovative special yarn solutions for the global market.


Ertex designs and produces fine filament jacquard fabric in a wide range of structures.

Industrial "Internet of Things

The wireless transmission of data is at the beginning of a new era of the Internet of Things. It is fundamentally changing the way we make decisions, manufacture products and maintain our factories. With low latency and ultra-reliable, highly secure wireless solutions, we are unlocking new applications for wireless communications in the Industrial Internet of Things.

R3 offers simple solutions for intelligent wireless controls of the future. The developed technology enables highly reliable real-time communication. The product range combines the reliability of a cable connection with the flexibility of wireless communication: like a cable without a wire. Areas of application are primarily in the field of automation as well as in the transport and logistics sector.


Change is the requirement for every improvement.

Be brave, try new things and invest in the future! Since 2000, we have been committed to innovations outside our core areas. We are involved in various start-ups and have been managing two venture funds since 2000, one of which has already been successfully completed.

BICO Group

BICO is the world's leading bioconvergence company, providing high-quality bioinks, bioprinters and services that enable critical breakthroughs in 3D cell cultivation, tissue engineering and drug development.


CellAct Pharma develops innovative chemotherapies for the treatment of cancer. The leading clinical candidate from CellAct, CAP7.1, is a new modification of the established chemotherapy medication Etoposide developed at the Charité hospital in Berlin. The programme is currently preparing for an international phase III study in readiness for market approval in the Europe and the USA.

CBF-Venture Fund

We participate in a venture capital fund, which invests in recently established companies in the field of healthcare. We manage this fund together with our strong partners through Peppermint VenturePartners GmbH. Our CBF-1 venture portfolio currently includes eight companies from the areas of medical technology, diagnostics and digital health as well as platform-based healthcare technologies. All these companies have won us over with their innovative ideas.


authentic delivers blockchain-based realtime certification. Using blockchain technology, products, medications and documents can be check to ensure they are authentic and genuine using a combination of patented printing and scanning technologies.

ETHCL Food Labs GmbH

Healthy nutrition is very important to us. Especially in hectic times, it is important for us to reach for a healthy snack. Peppermint has therefore acquired a stake in ETHCL Food Labs GmbH through a merger. With the brand TZAMPAS, the Berlin start-up offers energy bars based on the roasted barley flour of the same name. The naturalness of the ingredients has top priority.